XML 13 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Balance Sheets - USD ($)
$ in Millions
Jun. 30, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 2,402 $ 1,975
Accounts receivables, net of allowance for credit losses of $129 million and $135 million as of June 30, 2020 and December 31, 2019 4,545 5,676
Inventories 4,361 4,422
Prepaid expenses 956 870
Other current assets 448 434
Assets held for sale 69 87
Total current assets 12,781 13,464
Deferred income taxes 483 386
Other non-current assets 560 591
Property, plant and equipment, net 6,122 6,436
Operating lease right-of-use assets 489 514
Identifiable intangible assets, net 9,940 11,232
Goodwill [1] 24,616 24,846
Total assets 54,991 57,470
Current liabilities:    
Short-term debt 1,649 2,345
Sales reserves and allowances 5,201 6,159
Accounts payables 1,606 1,718
Employee-related obligations 544 693
Accrued expenses 1,755 1,869
Other current liabilities 995 889
Total current liabilities 11,751 13,674
Long-term liabilities:    
Deferred income taxes 975 1,096
Other taxes and long-term liabilities 2,411 2,640
Senior notes and loans 24,616 24,562
Operating lease liabilities 414 435
Total long-term liabilities 28,417 28,733
Commitments and contingencies, see note 10  
Total liabilities 40,167 42,407
Teva shareholders' equity:    
Ordinary shares of NIS 0.10 par value per share; June 30, 2020 and December 31, 2019: authorized 2,495 million shares; issued 1,202 million shares and 1,198 million shares, respectively 57 56
Additional paid-in capital 27,374 27,312
Accumulated deficit (6,747) (6,956)
Accumulated other comprehensive loss (2,703) (2,312)
Treasury shares as of June 30, 2020 and December 31, 2019 — 107 million ordinary shares and 106 million ordinary shares, respectively (4,128) (4,128)
Stockholders' equity attributable to Teva shareholders 13,852 13,972
Non-controlling interests 972 1,091
Total equity 14,824 15,063
Total liabilities and equity $ 54,991 $ 57,470
[1] Accumulated goodwill impairment as of June 30, 2020 and December 31, 2019 was approximately $21.0 billion.